An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome-Reference-Cited by-同舟云学术

An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome

Published:2019-08 Issue:8 Volume:9 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Sawyer Jeffrey R.,Tian Erming,Walker Brian A.^ORCID,Wardell Christopher,Lukacs Janet L.,Sammartino Gael,Bailey Clyde,Schinke Carolina D.,Thanendrarajan Sharmilan,Davies Faith E.,Morgan Gareth J.,Barlogie Bart,Zangari Maurizio,van Rhee Frits

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-019-0226-4.pdf

Reference56 articles.

1. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature. 396, 643–649 (1998).

2. Geigl, J. B., Obenauf, A. C., Schwarzbraun, T. & Speicher, M. R. Defining chromosomal instability. Trends Genet. 24, 64–69 (2008).

3. Bakhoum, S. F. & Landau, D. A. Chromosomal instability as a driver of tumor heterogeneity and evolution. Cold Spring Harb. Perspect. Med. 7, a029611 (2017).

4. Sansregret, L., Vanhaesebroeck, B. & Swanton, C. Determinants and clinical implications of chromosomal instability in cancer. Nat. Rev. Clin. Onclol. 15, 139–150 (2018).

5. Kumar, S. K. & Rajkumar, S. V. The multiple myelomas—current concepts in cytogenetic classification and therapy. Nat. Rev. Clin. Oncol. 15, 409–421 (2018).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase–Related Mesenchymal Tumors;Modern Pathology;2024-09

2. Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells;Blood Cancer Journal;2024-06-07

3. Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies;American Society of Clinical Oncology Educational Book;2024-06

4. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

5. Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma;Leukemia;2024-04-12